BOSTON–(BUSINESS WIRE)–The Termeer Foundation is proud to announce the Class of 2023 Termeer Fellows. The Henri Termeer Fellowship Program is named in honor of the late Henri Termeer, a visionary leader in the biotechnology industry and designed to support first time CEOs who are patient focused and working to meet an unmet need through innovative … [Read more…]
KNOXVILLE, Tenn.–(BUSINESS WIRE)–Priority OnDemand (“the Company”), a national leader in medical transportation and mobile health solutions, announced today the release of its inaugural Environment, Social and Governance (ESG) Report, highlighting its initiatives and best practices to drive sustainable, equitable and governance best practices. “We are very proud to share our 2023 ESG report and to … [Read more…]
The genetic tuning innovator adds pioneering genetic medicine expert and an accomplished biotechnology lawyer to its management team. DURHAM, N.C. & SEATTLE–(BUSINESS WIRE)–Today, leading epigenomic editing company Tune Therapeutics introduced two members to its leadership team: Chief Scientific Officer, Derek Jantz, Ph.D., and General Counsel, Zachary Hale, J.D. Dr. Jantz comes to Tune with deep … [Read more…]
DALLAS–(BUSINESS WIRE)–Cariloop today announced those living with multiple sclerosis (MS) and their caregivers may now access its caregiver support services at select Walgreens neurology-specialty pharmacies. Cariloop’s platform for caregivers combines professional coaching services and cloud-based tools that help families plan for and manage every aspect of their caregiving journey. In this program, individuals with MS … [Read more…]
Following a record-breaking fundraising year in 2022, Walgreens nationwide are selling Red Noses and accepting in-store donations to support Red Nose Day 2023 DEERFIELD, Ill.–(BUSINESS WIRE)–Today, Walgreens nationwide kick off sales and in-store donations for the ninth annual Red Nose Day campaign to support healthy communities and help end the cycle of child poverty. Now … [Read more…]
IRVINE, Calif.–(BUSINESS WIRE)–#AUA2023—CG Oncology, Inc. today announced acceptance of an oral presentation at the American Urological Association (AUA) 2023 Annual Meeting in Chicago, IL from April 28-May 1, 2023. The updated data will be presented from the CORE-001 study, an ongoing Phase 2 clinical trial of cretostimogene grenadenorepvec (CG0070) in combination with Merck’s anti-PD-1 therapy … [Read more…]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea (OSA) and related disorders, including its lead oral treatment candidate AD109, today announced that Company management will present and host one-on-one investor meetings at the 22nd Needham Healthcare Conference taking place virtually April 17-20, … [Read more…]
Healthtech company adds key clinical expertise as it moves closer to commercialization of its next-generation blood testing ecosystem AUSTIN, Texas–(BUSINESS WIRE)–#BloodTesting–Babson Diagnostics, a science-first health care technology company, today announced the addition of a clinical advisor who will bring valuable insights of the medical community in the ongoing development and introduction of the company’s new … [Read more…]
Researchers highlight the importance of next-generation technologies as strategic tools for drug discovery WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL #LIFEatCRL–Charles River Laboratories International, Inc. (NYSE: CRL) today announced that its team of oncology experts will attend the American Association for Cancer Research (AACR) Annual Meeting, with 19 scientific posters and a spotlight presentation to highlight its enhanced oncology … [Read more…]
GROTON, Conn.–(BUSINESS WIRE)–Astrocyte Pharmaceuticals Inc., a private drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries, today announced that Theodore Liston, Ph.D., Vice President of Research at Astrocyte, received the 2022 Progress and Innovation Award from the journal Stroke for authoring one of the journal’s top three publications in 2022. … [Read more…]
